Premium
The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis
Author(s) -
Wang Shaoguang,
Meng Xiaomei,
Dong Yaozhong
Publication year - 2016
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2015.09.016
Subject(s) - medicine , adenomyosis , uterine artery embolization , uterine artery , pelvic pain , adverse effect , amenorrhea , hysterectomy , prospective cohort study , surgery , embolization , endometriosis , gynecology , pregnancy , gestation , biology , genetics
Objective To evaluate the safety and efficacy of uterine artery embolization (UAE) for the treatment of adenomyosis. Methods A prospective study was performed at Yuhuangding Hospital, China, between January 2012 and December 2013, enrolling premenopausal patients diagnosed with adenomyosis. All patients were treated with bilateral UAE using 500–700‐μm tris‐acryl gelatin microspheres. At baseline, and 3, 6, and 12 months after UAE, magnetic resonance imaging was used to assess uterine volume and patient‐assessed improvements in dysmenorrhea were recorded. Any complications and adverse events were reported. Results In total, 117 patients with adenomyosis were enrolled. The bilateral UAE procedure was successful in 115 (98.3%) patients, who were able to return to normal activity within 1 week of treatment. At 12‐month follow‐up, a median 51.0% reduction in uterine volume from baseline was recorded ( P = 0.005). Marked and moderate improvements in dysmenorrhea symptoms were reported by 64 (55.7%) and 31 (27.0%) participants, respectively. Pelvic pain of varying intensity was reported by 112 (97.4%) patients but was managed with analgesia. Persistent amenorrhea was experienced by 2 (1.7%) individuals following treatment. Patients did not encounter any new gynecologic or general complications following UAE treatment. Conclusion UAE could be considered as a minimally invasive treatment option for patients with adenomyosis. Further research to compare the efficacy and safety of UAE with conventional hysterectomy is warranted.